Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Floreane's Sofradim builds US structure

This article was originally published in Clinica

Executive Summary

Sofradim, the US subsidiary set up by France's Floreane Medical Implants, is targeting the establishment of a US sales force of up to 40 representatives in the near future, says the Trevoux-based parent company. Sofradim, which recently expanded its management staff to five under president William Barrett, is currently planning distribution of its newly approved urological implant, Uretex. Its business so far has been from early sales of four FDA-approved parietal implants. The Boston-based subsidiary has made sales of E90,000 ($80,000) in its first three months of operation, and has targeted full-year 2002 sales of E1 million.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064586

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel